180 related articles for article (PubMed ID: 36036471)
21. Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level.
Oh J; Kang CI; Kim SH; Huh K; Cho SY; Chung DR; Lee SY; Jung CW; Peck KR
Mycoses; 2020 Jan; 63(1):89-94. PubMed ID: 31610064
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center.
Van Matre ET; Evans SL; Mueller SW; MacLaren R; Fish DN; Kiser TH
Ann Clin Microbiol Antimicrob; 2019 Mar; 18(1):13. PubMed ID: 30894179
[TBL] [Abstract][Full Text] [Related]
23. Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.
Cámara R; Gozalbo I; Jurado M; Sanz J; Aragón B; Grau S
Adv Ther; 2017 Sep; 34(9):2104-2119. PubMed ID: 28808915
[TBL] [Abstract][Full Text] [Related]
24. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
25. Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report.
Weeraphon B; Vanichanan J; Usayaporn S
J Clin Pharm Ther; 2020 Dec; 45(6):1486-1488. PubMed ID: 32686229
[TBL] [Abstract][Full Text] [Related]
26. Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation.
Döring M; Blume O; Haufe S; Hartmann U; Kimmig A; Schwarze CP; Lang P; Handgretinger R; Müller I
Eur J Clin Microbiol Infect Dis; 2014 Apr; 33(4):629-38. PubMed ID: 24173819
[TBL] [Abstract][Full Text] [Related]
27. Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
Shoham S; Ostrander D; Marr K
Transpl Infect Dis; 2015 Jun; 17(3):493-6. PubMed ID: 25846433
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Grau S; Cámara R; Jurado M; Sanz J; Aragón B; Gozalbo I
Eur J Health Econ; 2018 May; 19(4):627-636. PubMed ID: 28569350
[TBL] [Abstract][Full Text] [Related]
29. Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study.
Copley MS; Waldron M; Athans V; Welch SC; Brizendine KD; Cober E; Siebenaller C
Int J Antimicrob Agents; 2020 Mar; 55(3):105886. PubMed ID: 31926286
[TBL] [Abstract][Full Text] [Related]
30. Voriconazole prophylaxis in leukemic patients: A retrospective single-center study.
Bui V; Walker SA; Elligsen M; Vyas A; Kiss A; Palmay L
J Oncol Pharm Pract; 2020 Jun; 26(4):873-881. PubMed ID: 31566111
[TBL] [Abstract][Full Text] [Related]
31. A novel highly bio-available itraconazole formulation (SUBA®-Itraconazole) for anti-fungal prophylaxis in lung transplant recipients.
Whitmore TJ; Yaw M; Lavender M; Musk M; Boan P; Wrobel J
Transpl Infect Dis; 2021 Aug; 23(4):e13587. PubMed ID: 33590676
[TBL] [Abstract][Full Text] [Related]
32. Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies.
Almutairy R; Khan MA; Shahbar A; Aseeri M; Alshamrani M; Almarhabi H; Naeem D
J Oncol Pharm Pract; 2024 Apr; ():10781552241246119. PubMed ID: 38656201
[TBL] [Abstract][Full Text] [Related]
33. Breakthrough invasive fungal infection in patients with myeloid malignancy receiving posaconazole tablet prophylaxis: Clinical features, risk factors, and posaconazole profiles.
Hong JY; Kang CI; Yang J; Ko JH; Huh K; Cho SY; Chung DR; Jung CW; Peck KR
Med Mycol; 2023 Apr; 61(5):. PubMed ID: 37120735
[TBL] [Abstract][Full Text] [Related]
34. Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses.
Tverdek FP; Heo ST; Aitken SL; Granwehr B; Kontoyiannis DP
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507111
[TBL] [Abstract][Full Text] [Related]
35. Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients.
Samanta P; Clancy CJ; Marini RV; Rivosecchi RM; McCreary EK; Shields RK; Falcione BA; Viehman A; Sacha L; Kwak EJ; Silveira FP; Sanchez PG; Morrell M; Clarke L; Nguyen MH
Clin Infect Dis; 2021 Aug; 73(3):416-426. PubMed ID: 32463873
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for subtherapeutic levels of posaconazole tablet.
Tang LA; Marini BL; Benitez L; Nagel JL; Miceli M; Berglund C; Perissinotti AJ
J Antimicrob Chemother; 2017 Oct; 72(10):2902-2905. PubMed ID: 29091205
[TBL] [Abstract][Full Text] [Related]
37. Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections.
Furuno JP; Tallman GB; Noble BN; Bubalo JS; Forrest GN; Lewis JS; Bienvenida AF; Holmes CA; Weber BR; McGregor JC
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012757
[TBL] [Abstract][Full Text] [Related]
38. Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients.
Hashemizadeh Z; Badiee P; Malekhoseini SA; Raeisi Shahraki H; Geramizadeh B; Montaseri H
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923870
[TBL] [Abstract][Full Text] [Related]
39. Impact of patient education on plasma concentrations and effectiveness of posaconazole oral suspension under clinical conditions.
Geist MJP; Egerer G; Mikus G; Blank A; Hohmann N; Heinz WJ; Carls A
Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):56-61. PubMed ID: 29989301
[TBL] [Abstract][Full Text] [Related]
40. Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis.
Thanukrishnan H; Corcoran TE; Iasella CJ; Moore CA; Nero JA; Morrell MR; McDyer JF; Hussain S; Nguyen MH; Venkataramanan R; Ensor CR
Transplantation; 2019 Dec; 103(12):2608-2613. PubMed ID: 31343565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
